Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Allergic Reactions02:06

Allergic Reactions

27.3K
Overview
27.3K
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

764
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
764
Hypersensitivities01:30

Hypersensitivities

580
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
580
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

270
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
270
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

384
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
384

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome: A phase 2 study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Stability of epinephrine nasal spray under room temperature, freeze-thaw, and extreme temperature conditions.

The journal of allergy and clinical immunology. In practice·2026
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Anaphylaxis Guidelines.

Immunology and allergy clinics of North America·2026
Same author

Venom Anaphylaxis.

Immunology and allergy clinics of North America·2026
Same author

Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis.

JAMA pediatrics·2026

相关实验视频

Updated: Jun 22, 2025

Measuring Local Anaphylaxis in Mice
07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

19.4K

实践中的过敏反应:2023年实践参数更新指南

Julie Wang1, Jay A Lieberman2, Dana V Wallace3

  • 1Division of Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY.

The journal of allergy and clinical immunology. In practice
|June 29, 2024
PubMed
概括

"2023年阿纳菲拉克西斯实践参数更新"提供了新的诊断标准和管理策略. 上腺素不是用于诊断;专注于个性化风险评估和患者护理的共享决策.

关键词:
过敏反应 (ANAPHYLAXIS) 是一种过敏反应.上腺素的使用情况.巨细胞疾病 巨细胞疾病在外科手术期间出现过敏反应.实践参数是一个实践参数.试酶是一种三酶.毒药免疫疗法是一种毒药免疫疗法.

更多相关视频

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.3K

相关实验视频

Last Updated: Jun 22, 2025

Measuring Local Anaphylaxis in Mice
07:49

Measuring Local Anaphylaxis in Mice

Published on: October 14, 2014

19.4K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.3K

科学领域:

  • 过敏和免疫学 过敏和免疫学
  • 临床实践指南 临床实践指南
  • 紧急医疗 紧急医疗

背景情况:

  • 过敏反应的诊断和管理需要更新的临床指导.
  • 之前的实践参数是在2015年建立的.
  • 新的证据需要对过敏反应护理进行修订.

研究的目的:

  • 总结2023年实践参数联合工作组的关键更新. 过敏反应实践参数更新.
  • 突出对过敏反应诊断和管理的新和不断变化的建议.
  • 为临床医生提供有关过敏反应护理近期进展的可访问信息.

主要方法:

  • 自2015年实践参数以来的新兴研究和临床证据的审查.
  • 分析更新的诊断标准和管理策略.
  • 对临床实践的综合建议.

主要成果:

  • 引入新的过敏反应诊断标准.
  • 澄清了定义高酸酶水平的规则.
  • 在婴儿和幼儿中增强对过敏反应症状的识别.
  • 强调,上腺素的使用不是诊断工具.
  • 关于对过敏反应风险因素的个案评估的建议.
  • 强调患者咨询和共同决策的重要性.
  • 在家庭使用上腺素后,何时可能不需要激活紧急医疗服务的指导.

结论:

  • "2023年过敏反应实践参数"为临床决策提供了关键的更新.
  • 个性化风险评估和共享决策是现代过敏反应管理的核心.
  • 临床医生应查阅完整的2023参数,以获得全面的基于证据的建议.